{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T16:10:04Z","timestamp":1749053404404,"version":"3.41.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Lundbeck A\/S"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain Research"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.brainres.2016.08.004","type":"journal-article","created":{"date-parts":[[2016,8,6]],"date-time":"2016-08-06T01:34:36Z","timestamp":1470447276000},"page":"298-305","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"PA","title":["Discriminative stimulus properties of 1.25 mg\/kg clozapine in rats: Mediation by serotonin 5-HT 2 and dopamine D 4 receptors"],"prefix":"10.1016","volume":"1648","author":[{"given":"Adam J.","family":"Prus","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura E.","family":"Wise","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan L.","family":"Pehrson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott D.","family":"Philibin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benny","family":"Bang-Andersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00f8rn","family":"Arnt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph H.","family":"Porter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.brainres.2016.08.004_bib1","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s00213-009-1521-8","article-title":"Amisulpride is a potent 5-HT7 antagonist: relevance for antidepressant actions in vivo","volume":"205","author":"Abbas","year":"2009","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.brainres.2016.08.004_bib2","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0893-133X(97)00112-7","article-title":"Do novel antipsychotics have similar pharmacological characteristics? A review of the evidence","volume":"18","author":"Arnt","year":"1998","journal-title":"Neuropsychopharmacology"},{"issue":"6","key":"10.1016\/j.brainres.2016.08.004_bib3","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/S0968-0896(02)00459-5","article-title":"Synthesis and structure-affinity relationship investigations of 5-aminomethyl and 5-carbamoyl analogues of the antipsychotic sertindole. A new class of selective alpha1 adrenoceptor antagonists","volume":"11","author":"Balle","year":"2003","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.brainres.2016.08.004_bib4","unstructured":"Bang-Andersen, B., Felding, J., Kehler, J., 2002. Indol derivatives useful for the treatment of CNS disorders, PCT application no. WO2007\/019867"},{"key":"10.1016\/j.brainres.2016.08.004_bib5","unstructured":"Bang-Andersen, B., Larsen, K., M\u00f8rk, N., 2007. Novel 2,3-dihydroindole compounds, PCT application no. WO 02\/00645"},{"issue":"2","key":"10.1016\/j.brainres.2016.08.004_bib6","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/S0022-3565(25)11335-9","article-title":"Antagonism by antimuscarinic and neuroleptic compounds at the five cloned human muscarinic cholinergic receptors expressed in Chinese hamster ovary cells","volume":"260","author":"Bolden","year":"1992","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"3","key":"10.1016\/j.brainres.2016.08.004_bib7","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0893-133X(95)00068-O","article-title":"New insights into the biology of schizophrenia through the mechanism of action of clozapine","volume":"13","author":"Brunello","year":"1995","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"10.1016\/j.brainres.2016.08.004_bib8","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0893-133X(94)00129-N","article-title":"Radioreceptor binding profile of the atypical antipsychotic olanzapine","volume":"14","author":"Bymaster","year":"1996","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.brainres.2016.08.004_bib9","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.2147\/NDT.S83989","article-title":"Rare and very rare adverse effects of clozapine","volume":"11","author":"De Fazio","year":"2015","journal-title":"Neuropsychiatr. Dis. Treat."},{"issue":"5","key":"10.1016\/j.brainres.2016.08.004_bib10","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/S0028-3908(03)00040-6","article-title":"Generalization of clozapine as compared to other antipsychotic agents to a discriminative stimulus elicited by the serotonin (5-HT)2A antagonist, MDL100,907","volume":"44","author":"Dekeyne","year":"2003","journal-title":"Neuropharmacology"},{"issue":"4","key":"10.1016\/j.brainres.2016.08.004_bib11","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/S0893-133X(01)00389-X","article-title":"The selective serotonin(2A) receptor antagonist, MDL100,907, elicits a specific interoceptive cue in rats","volume":"26","author":"Dekeyne","year":"2002","journal-title":"Neuropsychopharmacology"},{"year":"1964","series-title":"Biostatistics: An Introductory Text","author":"Goldstein","key":"10.1016\/j.brainres.2016.08.004_bib12"},{"key":"10.1016\/j.brainres.2016.08.004_bib13","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.pbb.2003.10.012","article-title":"Stimulus properties of the \u201catypical\u201d antipsychotic zotepine in rats: comparisons with clozapine and quetiapine","volume":"77","author":"Goudie","year":"2004","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"8","key":"10.1016\/j.brainres.2016.08.004_bib14","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1097\/00008877-199812000-00006","article-title":"Discriminative stimulus properties of the atypical neuroleptic clozapine in rats: tests with subtype selective receptor ligands","volume":"9","author":"Goudie","year":"1998","journal-title":"Behav. Pharmacol."},{"issue":"1\u20133","key":"10.1016\/j.brainres.2016.08.004_bib15","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ejphar.2007.06.052","volume":"573","author":"Hertel","year":"2007","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.brainres.2016.08.004_bib16","article-title":"The discriminative stimulus effects of clozapine in pigeons: involvement of 5-hydroxytryptamine1C and 5-hydroxytryptamine2 receptors","volume":"263","author":"Hoenicke","year":"1992","journal-title":"J. Pharmacol.\u00a0Exp. Ther."},{"issue":"3","key":"10.1016\/j.brainres.2016.08.004_bib17","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/BF00606409","article-title":"Agranulocytosis during treatment with chlozapine","volume":"11","author":"Idanpaan-Heikkila","year":"1977","journal-title":"Eur. J. Clin. Pharm."},{"issue":"1","key":"10.1016\/j.brainres.2016.08.004_bib18","first-page":"62","article-title":"Clozapine in treatment-resistant schizophrenics","volume":"24","author":"Kane","year":"1988","journal-title":"Psychopharmacol. Bull."},{"key":"10.1016\/j.brainres.2016.08.004_bib19","doi-asserted-by":"crossref","DOI":"10.1124\/jpet.102.046987","article-title":"Antipsychotic dosing is preclinical models is often unrepresentative of the clinical condition: a suggested solution based on in vivo occupancy","volume":"305","author":"Kapur","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"4","key":"10.1016\/j.brainres.2016.08.004_bib20","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/S0091-3057(96)00342-5","article-title":"The role of muscarinic cholinergic receptors in the discriminative stimulus properties of clozapine in rats","volume":"57","author":"Kelley","year":"1997","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"7","key":"10.1016\/j.brainres.2016.08.004_bib21","article-title":"Clozapine \u2013 a potential antipsychotic agent without extrapyramidal manifestations","volume":"16","author":"Matz","year":"1974","journal-title":"Curr. Ther. Res. Clin. Exp."},{"issue":"2","key":"10.1016\/j.brainres.2016.08.004_bib22","doi-asserted-by":"crossref","DOI":"10.1093\/oxfordjournals.schbul.a033376","article-title":"The effects of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia","volume":"25","author":"Meltzer","year":"1999","journal-title":"Schizophr. Bull."},{"issue":"1","key":"10.1016\/j.brainres.2016.08.004_bib23","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.coph.2011.02.007","article-title":"The role of serotonin receptors in the action of atypical antipsychotic drugs","volume":"11","author":"Meltzer","year":"2011","journal-title":"Curr. Opin. Pharmacol."},{"issue":"Suppl 12","key":"10.1016\/j.brainres.2016.08.004_bib24","first-page":"S47","article-title":"Suicide and schizophrenia: clozapine and the InterSePT study. International clozaril\/leponex suicide prevention trial","volume":"60","author":"Meltzer","year":"1999","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.brainres.2016.08.004_bib25","series-title":"Neuropsychopharmacology: the Fifth Generation of Progress: An Official Publication of the American College of Neuropsychopharmacology","article-title":"Mechanism of action of atypical antipsychotic drugs","author":"Meltzer","year":"2002"},{"key":"10.1016\/j.brainres.2016.08.004_bib26","series-title":"Handbook of Contemporary Neuropharmacology","article-title":"Atypical antipsychotic drugs: mechanism of action","author":"Meltzer","year":"2007"},{"issue":"3","key":"10.1016\/j.brainres.2016.08.004_bib27","doi-asserted-by":"crossref","DOI":"10.1001\/archpsyc.1976.01770030003001","article-title":"The effect of neuroleptics on serum prolactin in schizophrenic patients","volume":"33","author":"Meltzer","year":"1976","journal-title":"Arch. Gen. Psychiatry"},{"issue":"1","key":"10.1016\/j.brainres.2016.08.004_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/S0022-3565(25)20710-8","article-title":"Classification of typical and atypical antipsychotic drugs on the basis of dopamine D-1, D-2 and serotonin2 pKi values","volume":"251","author":"Meltzer","year":"1989","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.brainres.2016.08.004_bib29","article-title":"Melperone and clozapine: neuroendocrine effects of atypical neuroleptic drugs","volume":"352","author":"Meltzer","year":"1989","journal-title":"Acta Psychiatr. Scand."},{"issue":"3","key":"10.1016\/j.brainres.2016.08.004_bib30","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1016\/S0022-3565(24)37732-8","volume":"286","author":"Millan","year":"1999","journal-title":"J. Pharmacol. experimental Ther."},{"issue":"1","key":"10.1016\/j.brainres.2016.08.004_bib31","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00213-004-1981-9","article-title":"Cerebral metabolic changes induced by clozapine in schizophrenia and related to clinical improvement","volume":"178","author":"Molina","year":"2005","journal-title":"Psychopharmacology"},{"issue":"2","key":"10.1016\/j.brainres.2016.08.004_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/S0022-3565(25)10792-1","article-title":"The behavioral pharmacology of olanzapine, a novel \"atypical\" antipsychotic agent","volume":"262","author":"Moore","year":"1992","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.brainres.2016.08.004_bib33","unstructured":"National Research Council Committee for the Update of the Guide for the Care and Use of Laboratory Animals, Institute for Laboratory Animal Research, National Academies Press. 2011. Guide for the care and use of laboratory animals. 8th ed. Washington, D.C.: National Academies Press, p xxv, 220 p."},{"issue":"1","key":"10.1016\/j.brainres.2016.08.004_bib34","doi-asserted-by":"crossref","DOI":"10.1007\/BF00735891","article-title":"Cholinergic mediation of the discriminative stimulus properties of clozapine","volume":"94","author":"Nielsen","year":"1988","journal-title":"Psychopharmacology"},{"issue":"2","key":"10.1016\/j.brainres.2016.08.004_bib35","doi-asserted-by":"crossref","DOI":"10.1038\/sj.npp.1300819","article-title":"Evidence for the preferential involvement of 5-HT2A serotonin receptors in stress- and drug-induced dopamine release in the rat medial prefrontal cortex","volume":"31","author":"Pehek","year":"2006","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.brainres.2016.08.004_bib36","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s00213-005-2147-0","article-title":"Serotonin receptor mechanisms mediate the discriminative stimulus properties of the atypical antipsychotic clozapine in C57BL\/6 mice","volume":"180","author":"Philibin","year":"2005","journal-title":"Psychopharmacology"},{"issue":"2","key":"10.1016\/j.brainres.2016.08.004_bib37","doi-asserted-by":"crossref","DOI":"10.1007\/s00213-008-1385-3","article-title":"Further characterization of the discriminative stimulus properties of the atypical antipsychotic drug clozapine in C57BL\/6 mice: role of 5-HT(2A) serotonergic and alpha (1) adrenergic antagonism","volume":"203","author":"Philibin","year":"2009","journal-title":"Psychopharmacology"},{"issue":"2","key":"10.1016\/j.brainres.2016.08.004_bib38","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s00213-008-1308-3","article-title":"Discriminative stimulus properties of atypical and typical antipsychotic drugs: a review of preclinical studies","volume":"203","author":"Porter","year":"2009","journal-title":"Psychopharmacology"},{"issue":"1","key":"10.1016\/j.brainres.2016.08.004_bib39","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s00213-004-1985-5","article-title":"Discriminative stimulus properties of the atypical antipsychotic clozapine and the typical antipsychotic chlorpromazine in a three-choice drug discrimination procedure in rats","volume":"178","author":"Porter","year":"2005","journal-title":"Psychopharmacology"},{"issue":"2","key":"10.1016\/j.brainres.2016.08.004_bib40","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s002139900366","article-title":"Clozapine discrimination with a low training dose distinguishes atypical from typical antipsychotic drugs in rats","volume":"149","author":"Porter","year":"2000","journal-title":"Psychopharmacology"},{"issue":"5","key":"10.1016\/j.brainres.2016.08.004_bib41","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1097\/00004714-200110000-00004","article-title":"Clozapine enhances neurocognition and clinical symptomatology more than standard neuroleptics","volume":"21","author":"Potkin","year":"2001","journal-title":"J. Clin. Psychopharmacol."},{"issue":"2","key":"10.1016\/j.brainres.2016.08.004_bib42","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.pbb.2003.10.010","article-title":"Discriminative stimulus properties of 1.25 and 5.0 mg\/kg doses of clozapine in rats: examination of the role of dopamine, serotonin, and muscarinic receptor mechanisms","volume":"77","author":"Prus","year":"2004","journal-title":"Pharmacol., Biochem., Behav."},{"issue":"7","key":"10.1016\/j.brainres.2016.08.004_bib43","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1097\/01.fbp.0000172735.73876.06","article-title":"Generalization to atypical antipsychotic drugs depends on training dose in rats trained to discriminate 1.25 mg\/kg clozapine versus 5.0 mg\/kg clozapine versus vehicle in a three-choice drug discrimination task","volume":"16","author":"Prus","year":"2005","journal-title":"Behav. Pharmacol."},{"issue":"2","key":"10.1016\/j.brainres.2016.08.004_bib44","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/01.fbp.0000197457.70774.91","article-title":"Discriminative stimulus properties of the atypical antipsychotic drug clozapine in rats trained to discriminate 1.25 mg\/kg clozapine vs. 5.0 mg\/kg clozapine vs. vehicle","volume":"17","author":"Prus","year":"2006","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.brainres.2016.08.004_bib45","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/ddr.10419","article-title":"Generalization testing with atypical and typical antipsychotic drugs in rats trained to discriminate 5.0mg\/kg clozapine from vehicle in a two-choice drug discrimination task","volume":"64","author":"Prus","year":"2005","journal-title":"Drug Dev. Res"},{"issue":"3","key":"10.1016\/j.brainres.2016.08.004_bib46","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/BF02311185","article-title":"D4 dopamine receptor binding affinity does not distinguish between typical and atypical antipsychotic drugs","volume":"120","author":"Roth","year":"1995","journal-title":"Psychopharmacology"},{"issue":"1\u20132","key":"10.1016\/j.brainres.2016.08.004_bib47","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/BF02245606","article-title":"Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding","volume":"124","author":"Schotte","year":"1996","journal-title":"Psychopharmacology"},{"issue":"1","key":"10.1016\/j.brainres.2016.08.004_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/0014-2999(94)90643-2","article-title":"Blockade of the discriminative stimulus effects of DOI by MDL 100,907 and the 'atypical' antipsychotics, clozapine and risperidone","volume":"264","author":"Schreiber","year":"1994","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.brainres.2016.08.004_bib49","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1097\/FBP.0b013e328349ab37","article-title":"Role of training dose in drug discrimination: a review","volume":"22","author":"Stolerman","year":"2011","journal-title":"Behav. Pharmacol."}],"container-title":["Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899316305418?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899316305418?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T15:37:22Z","timestamp":1749051442000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006899316305418"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":49,"alternative-id":["S0006899316305418"],"URL":"https:\/\/doi.org\/10.1016\/j.brainres.2016.08.004","relation":{},"ISSN":["0006-8993"],"issn-type":[{"type":"print","value":"0006-8993"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discriminative stimulus properties of 1.25mg\/kg clozapine in rats: Mediation by serotonin 5-HT2 and dopamine D4 receptors","name":"articletitle","label":"Article Title"},{"value":"Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brainres.2016.08.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}